376594-64-8 Usage
Uses
Used in Pharmaceutical Industry:
(R)-N-(2-(4-Aminophenyl)propyl)propane-2-sulfonamide 4-Methylbenzenesulfonate is used as a sulfonamide-based drug for its potential therapeutic effects on various medical conditions, including inflammation and pain. (R)-N-(2-(4-aMinophenyl)propyl)propane-2-sulfonaMide 4-Methylbenzenesulfonate's unique structure and properties make it a promising candidate for the development of new medications.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (R)-N-(2-(4-Aminophenyl)propyl)propane-2-sulfonamide 4-Methylbenzenesulfonate is used as a subject of study for its potential applications in drug development. (R)-N-(2-(4-aMinophenyl)propyl)propane-2-sulfonaMide 4-Methylbenzenesulfonate's stability and solubility, attributed to the 4-Methylbenzenesulfonate counter-ion, make it an interesting candidate for further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 376594-64-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,7,6,5,9 and 4 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 376594-64:
(8*3)+(7*7)+(6*6)+(5*5)+(4*9)+(3*4)+(2*6)+(1*4)=198
198 % 10 = 8
So 376594-64-8 is a valid CAS Registry Number.
376594-64-8Relevant academic research and scientific papers
Synthesis of 14C-labeled and tritiated AMPA potentiator LY450108
Czeskis, Boris A.,O'Bannon, Douglas D.,Wheeler, William J.,Clodfelter, Dean K.
, p. 85 - 100 (2007/10/03)
Asymmetric synthesis of AMPA potentiator LY450108-[14C] containing 14C-label attached to the chiral center of the molecule, was accomplished based on Evans' chiral oxazolidinone auxiliary method. Diastereoselective methylation of p-n
Sulfonamide derivatives
-
Page 11, (2010/02/06)
The present invention relates to a compound of formula (Ia) or a pharmaceutically acceptable salt thereof which is useful for the treatment of conditions associated with glutamate hypofunction, such as psychiatric and neurological disorders. 1
Heterocyclic sulfonamide derivatives
-
Page 7, (2010/11/29)
The present invention provides certain heterocyclic sulfonamide derivatives of formula (I): useful for potentiating glutamate receptor function in a patient and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.
